Fenimore Asset Management’s Lumos Pharma, Inc. Common Stock LUMO Stock Holding History

Fenimore Asset Management’s Portfolio LUMO Stock Details LUMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-1,369	Closed	-$31K	–	124
2019 Q4	$31K	Hold	1,369	–	–	﹤0.01%	115
2019 Q3	$20K	Hold	1,369	–	–	﹤0.01%	120
2019 Q2	$18K	Hold	1,369	–	–	﹤0.01%	122
2019 Q1	$24K	Hold	1,369	–	–	﹤0.01%	117
2018 Q4	$19K	Hold	1,369	–	–	﹤0.01%	118
2018 Q3	$29K	Hold	1,369	–	–	﹤0.01%	119
2018 Q2	$59K	Hold	1,369	–	–	﹤0.01%	116
2018 Q1	$89K	Hold	1,369	–	–	﹤0.01%	112
2017 Q4	$100K	Hold	1,369	–	–	﹤0.01%	118
2017 Q3	$125K	Hold	1,369	–	–	0.01%	114
2017 Q2	$91K	Hold	1,369	–	–	﹤0.01%	105
2017 Q1	$297K	Hold	1,369	–	–	0.01%	96
2016 Q4	$127K	Hold	1,369	–	–	0.01%	97
2016 Q3	$185K	Hold	1,369	–	–	0.01%	100
2016 Q2	$139K	Hold	1,369	–	–	0.01%	100
2016 Q1	$224K	Hold	1,369	–	–	0.01%	100
2015 Q4	$448K	Hold	1,369	–	–	0.02%	91
2015 Q3	$442K	Hold	1,369	–	–	0.02%	96
2015 Q2	$545K	Hold	1,369	–	–	0.03%	92
2015 Q1	$674K	Hold	1,369	–	–	0.03%	86
2014 Q4	$490K	Hold	1,369	–	–	0.02%	92
2014 Q3	$264K	Hold	1,369	–	–	0.01%	96
2014 Q2	$327K	Hold	1,369	–	–	0.02%	92
2014 Q1	$350K	Hold	1,369	–	–	0.02%	90
2013 Q4	$271K	Hold	1,369	–	–	0.02%	97
2013 Q3	$231K	Hold	1,369	–	–	0.01%	98
2013 Q2	$243K	Buy	+1,369	New	+$194K	0.02%	106

Other funds holding LUMO

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return

LPC

Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Jefferies Group New York $12B AUM 6.2% 1-Year Est. Return

IFG

Investors Financial Group Plymouth, Minnesota $215M AUM 19.81% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Fenimore Asset Management's LUMO Position: Q1 2020 in Review

Fenimore Asset Management sold out of Lumos Pharma, Inc. Common Stock (LUMO) in Q1 2020, closing a stake of 1,369 shares — an estimated $31K sold.

Fenimore Asset Management first reported a position in LUMO in Q2 2013 and held it in 27 quarters. The position peaked at $674K in Q1 2015. 46 funds tracked by Wall St. Rank hold LUMO as of Q1 2020.

Fenimore Asset Management reported no remaining Lumos Pharma, Inc. Common Stock position as of Q1 2020 after selling out during the quarter.
Fenimore Asset Management sold 1,369 Lumos Pharma, Inc. Common Stock shares in Q1 2020, an estimated $31K.
Fenimore Asset Management first reported a position in Lumos Pharma, Inc. Common Stock in Q2 2013 and held it in 27 quarters.
Fenimore Asset Management's Lumos Pharma, Inc. Common Stock position peaked at $674K in Q1 2015.
46 funds tracked by Wall St. Rank held Lumos Pharma, Inc. Common Stock as of Q1 2020.

Based on Fenimore Asset Management's 13F filing for Q1 2020, filed 24 Apr 2020.